Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
Phase 3
×
Primary Myelofibrosis
×
30 days
×
Clear all
Filters
3
NCT04562389
2026-04-09
SENTRY
Karyopharm Therapeutics Inc
Phase 3
Active not recruiting
353 enrolled
NCT06351631
2026-04-02
MK-3543-017
Merck Sharp & Dohme LLC
Phase 3
Recruiting
400 enrolled
NCT04472598
2026-03-23
TRANSFORM-1
AbbVie
Phase 3
Completed
252 enrolled
17 charts
NCT05198960
2026-03-20
AVAJAK
University Hospital, Brest
Phase 3
Recruiting
1,308 enrolled